Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Targeted Therapy With Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers: A Phase II Study

NCT02973997 is registered in ClinicalTrials.gov with Academic and Community Cancer Research United as lead sponsor.

NCT NCT02973997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Targeted Therapy With Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers: A Phase II Study
Lead sponsor
Academic and Community Cancer Research United
Phase
Phase 2
Overall status
Completed
Start date
February 7, 2018
Completion date
October 8, 2023
Enrollment
57 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

columnar cell variant thyroid gland papillary carcinoma, follicular variant thyroid gland papillary carcinoma, metastatic thyroid gland follicular carcinoma, metastatic thyroid gland papillary carcinoma, poorly differentiated thyroid gland carcinoma, recurrent differentiated thyroid gland carcinoma, recurrent thyroid gland follicular carcinoma, recurrent thyroid gland papillary carcinoma, stage iii differentiated thyroid gland carcinoma ajcc v7, stage iii thyroid gland follicular carcinoma ajcc v7, stage iii thyroid gland papillary carcinoma ajcc v7, stage iv thyroid gland follicular carcinoma ajcc v7, stage iv thyroid gland papillary carcinoma ajcc v7, stage iva differentiated thyroid gland carcinoma ajcc v7, stage iva thyroid gland follicular carcinoma ajcc v7, stage iva thyroid gland papillary carcinoma ajcc v7, stage ivb differentiated thyroid gland carcinoma ajcc v7, stage ivb thyroid gland follicular carcinoma ajcc v7, stage ivb thyroid gland papillary carcinoma ajcc v7, stage ivc differentiated thyroid gland carcinoma ajcc v7, stage ivc thyroid gland follicular carcinoma ajcc v7, stage ivc thyroid gland papillary carcinoma ajcc v7, tall cell variant thyroid gland papillary carcinoma, thyroid gland hurthle cell carcinoma, unresectable differentiated thyroid gland carcinoma, unresectable thyroid gland carcinoma